文献速递精神分裂症与精神病性障碍心境障碍

利用人脑类器官培养推进精神疾病临床前模型

Advancing preclinical models of psychiatric disorders with human brain organoid cultures.
PubMed 文献 · Mol Psychiatry · 2022-08-10

本文综述比较了常用动物临床前测试范式与诱导多能干细胞培养技术,重点聚焦新兴的三维培养模型。综述回顾了三维培养复杂度的进展、在子宫内电活动的再现,以及精神病、心境和环境诱发性疾病的建模。文章讨论了这些快速扩展技术对寻找新研究方向、验证药物作用和再现人类疾病的效用。

要点

  • 精神疾病缺乏特征性病变和常规检查发现,临床前建模面临挑战。
  • 综述比较动物范式与诱导多能干细胞三维培养模型。
  • 三维培养在再现电活动和精神病、心境障碍建模方面有进展。

核心结论

  • 人脑类器官等三维培养技术可能有助于寻找新研究方向、验证药物作用和再现人类精神疾病。

研究设计与样本

  • 综述比较常用动物临床前测试范式与诱导多能干细胞培养技术,聚焦三维模型。

主要发现

  • 三维培养复杂度进展可再现子宫内电活动。
  • 三维培养已用于精神病、心境和环境诱发性疾病的建模。

关键数值与推荐

  • 原文未报告具体数值标准或推荐条款。

临床怎么用

  • 原文未报告具体临床实践推荐。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Psychiatric disorders are often distinguished from neurological disorders in that the former do not have characteristic lesions or findings from cerebrospinal fluid, electroencephalograms (EEGs), or brain imaging, and furthermore do not have commonly recognized convergent mechanisms. Psychiatric disorders commonly involve clinical diagnosis of phenotypic behavioral disturbances of mood and psychosis, often with a poorly understood contribution of environmental factors. As such, psychiatric disease has been challenging to model preclinically for mechanistic understanding and pharmaceutical development. This review compares commonly used animal paradigms of preclinical testing with evolving techniques of induced pluripotent cell culture with a focus on emerging three-dimensional models. Advances in complexity of 3D cultures, recapitulating electrical activity in utero, and disease modeling of psychosis, mood, and environmentally induced disorders are reviewed. Insights from these rapidly expanding technologies are discussed as they pertain to the utility of human organoid and other models in finding novel research directions, validating pharmaceutical action, and recapitulating human disease.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Dixon TA, Muotri AR. Advancing preclinical models of psychiatric disorders with human brain organoid cultures. Mol Psychiatry. 2022. PMID: 35948659. doi:10.1038/s41380-022-01708-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。